(PharmaNewsWire.Com, April 16, 2020 ) The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.
At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Tissue Diagnostics Market. We are working diligently to help companies take rapid decisions by studying:
The impact of COVID-19 on the Tissue Diagnostics Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market
The rapid shifts in the strategies of the Top 50 companies in the Tissue Diagnostics Market
The shifting short-term priorities of the top 50 companies’ clients and their client's clients
You can request an in-depth analysis detailing the impact of COVID-19 on the Tissue Diagnostics Market:
According to the recent report “Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022", published by MarketsandMarkets™, the global Tissue Diagnostics Market size is projected to grow from USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9% from 2016 to 2022.
Browse in-depth TOC on “Tissue Diagnostics Market”
The growth of this market is mainly due to the rising incidences of cancer, technological innovations in the area of tissue diagnostics, and increasing healthcare expenditure.
In 2017, consumables formed the largest segment of the market, by product
Based on product, the tissue diagnostics market is segmented primarily into consumables and instruments, of which consumables held the leading share in 2017. Their wide use in processing tissue samples and their repeated consumption in tissue diagnostics has ensured their dominance in the market. Instruments, on the other hand, are typically one-time purchases and thus hold a smaller market share.
Research laboratories to grow at the highest rate in the end-user market
The key end users of tissue diagnostics instruments and consumables are hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. Research laboratories form the fastest-growing end-user segment. The growth of this segmental market is fueled by rising research focusing on the development of complex and specialized tests.
North America dominated the tissue diagnostics market, by region, in 2017
The tissue diagnostics market is segmented into four major regions—North America, Europe, Asia, and the Rest of the World (RoW). North America was the largest market for tissue diagnostics in 2017, due to several factors such as the strong presence of market players in the region, the growing geriatric population and chronic disease incidence, and easy access to healthcare services.
At a global level, companies such as F. Hoffman-La Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan, Abcam (UK), Becton, Dickinson and Company (US), and QIAGEN (Netherlands).
Browse Adjacent Markets: Sepsis Diagnostics Market Research Reports & Consulting
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
